These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease. Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S. Neuroimage; 2021 Oct 01; 239():118302. PubMed ID: 34174391 [Abstract] [Full Text] [Related]
3. Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans. Finnema SJ, Nabulsi NB, Mercier J, Lin SF, Chen MK, Matuskey D, Gallezot JD, Henry S, Hannestad J, Huang Y, Carson RE. J Cereb Blood Flow Metab; 2018 Nov 01; 38(11):2041-2052. PubMed ID: 28792356 [Abstract] [Full Text] [Related]
8. Validation, kinetic modeling, and test-retest reproducibility of [18F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice. Bertoglio D, Zajicek F, Lombaerde S, Miranda A, Stroobants S, Wang Y, Dominguez C, Munoz-Sanjuan I, Bard J, Liu L, Verhaeghe J, Staelens S. J Cereb Blood Flow Metab; 2022 Oct 01; 42(10):1867-1878. PubMed ID: 35570828 [Abstract] [Full Text] [Related]
10. Assessment of cerebral drug occupancy in humans using a single PET-scan: A [11C]UCB-J PET study. Marstrand-Joergensen MR, Laurell GL, Herrmann S, Nasser A, Johansen A, Lund A, Andersen TL, Knudsen GM, Pinborg LH. Eur J Nucl Med Mol Imaging; 2024 Sep 01; 51(11):3292-3304. PubMed ID: 38758370 [Abstract] [Full Text] [Related]
11. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue. Koole M, van Aalst J, Devrome M, Mertens N, Serdons K, Lacroix B, Mercier J, Sciberras D, Maguire P, Van Laere K. Eur J Nucl Med Mol Imaging; 2019 Feb 01; 46(2):396-406. PubMed ID: 30121895 [Abstract] [Full Text] [Related]
12. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem. Bertoglio D, Verhaeghe J, Wyffels L, Miranda A, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M, Bard J, Liu L, Munoz-Sanjuan I, Staelens S. J Nucl Med; 2022 Jun 01; 63(6):942-947. PubMed ID: 34531262 [Abstract] [Full Text] [Related]
14. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM. J Cereb Blood Flow Metab; 2021 Apr 01; 41(4):819-830. PubMed ID: 32538280 [Abstract] [Full Text] [Related]
16. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, Mievis F, Mestdagh N, Buchanan T, Valade A, Mercier J, Wood M, Gillard M, Seret A, Luxen A, Salmon E, Plenevaux A. J Nucl Med; 2014 Aug 01; 55(8):1336-41. PubMed ID: 24935992 [Abstract] [Full Text] [Related]
18. Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain. Thomsen MB, Schacht AC, Alstrup AKO, Jacobsen J, Lillethorup TP, Bærentzen SL, Noer O, Orlowski D, Elfving B, Müller HK, Brooks DJ, Landau AM. Mol Imaging Biol; 2020 Oct 01; 22(5):1290-1300. PubMed ID: 32514885 [Abstract] [Full Text] [Related]
19. Identification of pre-synaptic density networks using [11C]UCB-J PET imaging and ICA in mice. Akkermans J, Zajicek F, Miranda A, Adhikari MH, Bertoglio D. Neuroimage; 2022 Dec 01; 264():119771. PubMed ID: 36436710 [Abstract] [Full Text] [Related]